Site içinde arama yapın

Akash Motar bir ses eklendi Other
2025-11-20 14:01:39 -

Kirsten Rat Sarcoma (KRAS) Market – Oncology Breakthroughs & Targeted Therapy Outlook
"Future of Executive Summary Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market research report is a sure solution to get market insights with which...

0 Yorumlar 0 hisse senetleri 250 Views 0 önizleme

Please log in to like, share and comment!
Akash Motar bir ses eklendi Other
2025-12-09 17:00:23 -

Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology Landscape
Executive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...

0 Yorumlar 0 hisse senetleri 74 Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2025-12-15 07:07:33 -

Cell Cycle Inhibitors Market Advancing Targeted Cancer Treatments
In-Depth Study on Executive Summary Cell Cycle Inhibitors Market Size and Share CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. This Cell Cycle Inhibitors Market report is structured with the thorough market analysis carried...

0 Yorumlar 0 hisse senetleri 45 Views 0 önizleme

Please log in to like, share and comment!
Vikas Kokate bir ses eklendi Other
2025-07-30 10:58:44 -

Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032
"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...

0 Yorumlar 0 hisse senetleri 806 Views 0 önizleme

Please log in to like, share and comment!